The purpose of this study is to evaluate the fusion rate and clinical outcomes at 1 year of
20 patients with degenerative disc disease who undergo a Transforaminal Lumbar Interbody
Fusion (TLIF) with the Stryker Tritanium Spinal System. This is an on-label, post-market
outcomes study to build on the body of long-term evidence for the device.